The Role of Immune Modulation in Multiple Myeloma and Plasma Cell Dyscrasia

About this Research Topic

Background

It is well described that immune dysfunction is involved in the transformation of multiple myeloma (MM) from benign precursor states, smoldering myeloma, and monoclonal gammopathy of undetermined significance. The immune system in MM patients demonstrates progressive impairment with time. Mechanisms of immune impairment have been proposed to be involved in the fading tumor surveillance, production of immune-suppressive cytokines, suppression mediated by regulatory T-cells, myeloid-derived suppressor cells, tumor associated macrophages, and the expression of inhibitory immune checkpoints on cells present in the tumor microenvironment.

Emerging data suggests that attempts to revive and engage the innate and adaptive immune system can change the natural course of the disease. Efforts have been made to harness the immune response against multiple myeloma through the application of therapies such as IMiDS, monoclonal antibodies, autologous stem cell transplantation, chimeric antigen receptor T-cells, immune checkpoint blockades, bi-specifics antibodies, novel inhibitors, and epigenetic modulators. These immune/cancer cell therapies have led to tremendous advances in therapeutic options and prolonged the life expectancy of multiple myeloma patients. However, a subset of patients continues to be unresponsive, and nearly all patients succumb to their disease, thus emphasizing the need to further improve the therapeutic paradigm. Future work targeting immune defects in multiple myeloma is warranted to augment or restore T-cell or B-cell responses using the next generation of immune-modulating agents.

This Research Topic aims to address existing and novel strategies to advance combination immunotherapies in the preclinical and clinical settings of multiple myeloma and plasma cell dyscrasias. Particular attention will be given to hypothesis-driven studies with strong preliminary data and novel ideas to improve/enhance the long-lasting effects of these therapies.

We are interested in Original Research, Review/Mini Review, and Perspectives articles, focusing on but not limited to the following areas:

• Use of cellular therapies in MM and plasma cell dyscrasias
• Novel approaches to autologous or allogeneic transplantation
• Role of the microbiome as it correlates with treatment response
• Novel combinations with immune checkpoint inhibitors
• T- or B-cell exhaustion
• Changes in immune milieu with progression from smoldering to symptomatic myeloma
• Immune defects in multiple myeloma
• Bone marrow microenvironment
• Restoration of T-cell responses

In vitro and in vivo studies related to new immunotherapeutic approaches, clinical studies, population-based studies, novel target exploration, epigenetic insights, and biomarkers are of interest.

Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by robust and relevant validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this topic.


Dr. Noa Biran has research support from Karyopharm, Janssen, Amgen, and BMS and is on the speakers bureau of Pfizer, Janssen, and Sanofi. Dr. David Siegel receives honoraria and is on the speakers bureau of BMS, Karyopharm, Janssen Oncology, and GSK, receives honoraria from K36 Therapeutics and Sanofi, and is an equity holder in COTA. The other topic editors declare no competing interests with regard to the topic theme.

Keywords: multiple myeloma, plasma cell dyscrasia, immune dysfunction, cellular therapies, microbiome, immune checkpoint inhibitors, immune modulation, bone marrow, antibodies, cancer immunotherapy

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.